Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

17.35
Delayed Data
As of Jul 24
 +0.04 / +0.23%
Today’s Change
10.21
Today|||52-Week Range
19.35
+31.14%
Year-to-Date

Today’s Trading

Previous close17.31
Today’s open17.30
Day’s range16.93 - 17.51
Volume885,169
Average volume (3 months)367,488
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)-41.09%
Earnings growth (this year)+13.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.95

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+1.09+2.28%
AIMTAimmune Therapeutics...+0.24+1.10%
FWPForward Pharma A/S+0.48+2.17%
XNCRXencor Inc+0.39+1.64%
Data as of 4:00pm ET, 07/24/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$0.00
Annual profit (last year)-$176.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Paolo Tombesi
Corporate headquarters
Bridgewater, New Jersey

Forecasts